Updated BIOSECURE Act draft clears House committee
3 days ago · House Oversight Committee passes BIOSECURE Act, which would restrict US companies from contracting with Chinese biotechs, including WuXi AppTec, MGI, and BGI.
Anti-China BIOSECURE Act dealt blow, left out of defense bill - STAT
Dec 8, 2024 · WASHINGTON — Legislation to restrict U.S. drugmakers from using key Chinese contract manufacturers was dealt a major blow when senators left it out of a must-pass defense budget bill this weekend.
Reprieve for Chinese biotechs as BIOSECURE Act left out of key bill
Dec 9, 2024 · The BIOSECURE Act intends to prevent Chinese biotechs and manufacturers from accessing US funding and collaborating with US pharma companies. Image credit: Shutterstock/ fukomuffin.
Relief for Chinese biotechs as BIOSECURE Act delayed
Dec 9, 2024 · The BIOSECURE Act, which will prohibit businesses in the US from contracting with various Chinese firms on national security grounds, has not been included in a defence budget bill viewed as...
BIOSECURE Act Sails Through House Passage, Lines Up Senate Vote
Sep 10, 2024 · The U.S. House of Representatives on Monday voted in favor of the BIOSECURE Act, which would restrict American companies from working with specific Chinese biotech companies—potentially putting more pressure on an already-strained drug supply chain.
House passes bill that targets China biotechs - STAT
Sep 9, 2024 · The BIOSECURE Act would prohibit the U.S. government from contracting with, or providing grants to, companies that do business with a “biotechnology company of concern.” It specifically names...
BIOSECURE Act Absent in Key U.S. Defense Bill—Slim Chance of …
Dec 20, 2024 · Despite growing opposition and concerns from the U.S. biopharma industry, the BIOSECURE Act remains a contentious issue in Congress. Its exclusion from the 2025 National Defense Authorization Act leaves its future uncertain, but ongoing national security debates will keep it on the political agenda.
BIOSECURE Act Passed in the House of Representatives with a …
Sep 17, 2024 · Legislative Update on the BIOSECURE Act. On September 9, 2024, the House of Representatives passed HR 8333, 1 commonly known as the BIOSECURE Act. 2 The bill passed 306-81, far exceeding the two thirds vote required to pass.
BIOSECURE Act: Industry Closely Following in the Lame Duck
Nov 20, 2024 · As Congress returns for the lame duck session, the life sciences industry is closely watching the fate of the BIOSECURE Act, which would limit the ability of U.S. life sciences companies to work with ‘biotechnology companies of concern.’
New bill sets decoupling deadline for industry's work with WuXi
May 10, 2024 · Right after an industry survey suggested that switching away from Chinese CDMOs could take biopharma companies up to eight years, lawmakers have adjusted the BIOSECURE Act. The new draft lays out...